Literature DB >> 29700086

Hyperacute management of intracerebral haemorrhage.

Kyriaki Paroutoglou1, Adrian R Parry-Jones2.   

Abstract

Intracerebral haemorrhage causes 1 in 10 strokes, but has the worst overall outcomes of all stroke subtypes. Baseline haematoma volume is a key prognostic factor and early complications - such as haematoma expansion, obstructive hydrocephalus and perihaematomal oedema - may worsen outcome. There is evidence that withdrawal of care may occur more often in intracerebral haemorrhage than ischaemic stroke independent of premorbid health and stroke severity. However, recent evidence shows that reversal of anticoagulants, intensive blood pressure lowering and surgery in carefully selected cases may improve outcomes. Ongoing research may also provide evidence for new medical treatments and minimally invasive approaches to surgery. Effective implementation of evidence-based care to intracerebral haemorrhage patients can be difficult but quality improvement methodology can help to achieve maximal benefit. © Royal College of Physicians 2018. All rights reserved.

Entities:  

Keywords:  Hyperacute care; intracerebral haemorrhage

Mesh:

Substances:

Year:  2018        PMID: 29700086      PMCID: PMC6334033          DOI: 10.7861/clinmedicine.18-2-s9

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  22 in total

1.  Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage.

Authors:  S M Davis; J Broderick; M Hennerici; N C Brun; M N Diringer; S A Mayer; K Begtrup; T Steiner
Journal:  Neurology       Date:  2006-04-25       Impact factor: 9.910

2.  Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial.

Authors:  Daniel F Hanley; Karen Lane; Nichol McBee; Wendy Ziai; Stanley Tuhrim; Kennedy R Lees; Jesse Dawson; Dheeraj Gandhi; Natalie Ullman; W Andrew Mould; Steven W Mayo; A David Mendelow; Barbara Gregson; Kenneth Butcher; Paul Vespa; David W Wright; Carlos S Kase; J Ricardo Carhuapoma; Penelope M Keyl; Marie Diener-West; John Muschelli; Joshua F Betz; Carol B Thompson; Elizabeth A Sugar; Gayane Yenokyan; Scott Janis; Sayona John; Sagi Harnof; George A Lopez; E Francois Aldrich; Mark R Harrigan; Safdar Ansari; Jack Jallo; Jean-Louis Caron; David LeDoux; Opeolu Adeoye; Mario Zuccarello; Harold P Adams; Michael Rosenblum; Richard E Thompson; Issam A Awad
Journal:  Lancet       Date:  2017-01-10       Impact factor: 79.321

3.  Time course and predictors of neurological deterioration after intracerebral hemorrhage.

Authors:  Aaron S Lord; Emily Gilmore; H Alex Choi; Stephan A Mayer
Journal:  Stroke       Date:  2015-02-05       Impact factor: 7.914

4.  Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage.

Authors:  Craig S Anderson; Emma Heeley; Yining Huang; Jiguang Wang; Christian Stapf; Candice Delcourt; Richard Lindley; Thompson Robinson; Pablo Lavados; Bruce Neal; Jun Hata; Hisatomi Arima; Mark Parsons; Yuechun Li; Jinchao Wang; Stephane Heritier; Qiang Li; Mark Woodward; R John Simes; Stephen M Davis; John Chalmers
Journal:  N Engl J Med       Date:  2013-05-29       Impact factor: 91.245

5.  Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors.

Authors:  R Leira; A Dávalos; Y Silva; A Gil-Peralta; J Tejada; M Garcia; J Castillo
Journal:  Neurology       Date:  2004-08-10       Impact factor: 9.910

6.  Care-limiting decisions in acute stroke and association with survival: analyses of UK national quality register data.

Authors:  Adrian R Parry-Jones; Lizz Paley; Benjamin D Bray; Alex M Hoffman; Martin James; Geoffrey C Cloud; Pippa J Tyrrell; Anthony G Rudd
Journal:  Int J Stroke       Date:  2016-01-05       Impact factor: 5.266

7.  Reversal strategies for vitamin K antagonists in acute intracerebral hemorrhage.

Authors:  Adrian R Parry-Jones; Mario Di Napoli; Joshua N Goldstein; Floris H B M Schreuder; Sami Tetri; Turgut Tatlisumak; Bernard Yan; Koen M van Nieuwenhuizen; Nelly Dequatre-Ponchelle; Matthew Lee-Archer; Solveig Horstmann; Duncan Wilson; Fulvio Pomero; Luca Masotti; Christine Lerpiniere; Daniel Agustin Godoy; Abigail S Cohen; Rik Houben; Rustam Al-Shahi Salman; Paolo Pennati; Luigi Fenoglio; David Werring; Roland Veltkamp; Edith Wood; Helen M Dewey; Charlotte Cordonnier; Catharina J M Klijn; Fabrizio Meligeni; Stephen M Davis; Juha Huhtakangas; Julie Staals; Jonathan Rosand; Atte Meretoja
Journal:  Ann Neurol       Date:  2015-05-14       Impact factor: 10.422

8.  Reversibility of Apixaban Anticoagulation with a Four-Factor Prothrombin Complex Concentrate in Healthy Volunteers.

Authors:  S Nagalla; L Thomson; Y Oppong; B Bachman; I Chervoneva; W K Kraft
Journal:  Clin Transl Sci       Date:  2016-05-12       Impact factor: 4.689

9.  Four-factor prothrombin complex concentrate reverses apixaban-associated bleeding in a rabbit model of acute hemorrhage.

Authors:  E Herzog; F Kaspereit; W Krege; J Mueller-Cohrs; B Doerr; P Niebl; G Dickneite
Journal:  J Thromb Haemost       Date:  2015-11-24       Impact factor: 5.824

10.  Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial.

Authors:  Daniel F Hanley; Richard E Thompson; John Muschelli; Michael Rosenblum; Nichol McBee; Karen Lane; Amanda J Bistran-Hall; Steven W Mayo; Penelope Keyl; Dheeraj Gandhi; Tim C Morgan; Natalie Ullman; W Andrew Mould; J Ricardo Carhuapoma; Carlos Kase; Wendy Ziai; Carol B Thompson; Gayane Yenokyan; Emily Huang; William C Broaddus; R Scott Graham; E Francois Aldrich; Robert Dodd; Cristanne Wijman; Jean-Louis Caron; Judy Huang; Paul Camarata; A David Mendelow; Barbara Gregson; Scott Janis; Paul Vespa; Neil Martin; Issam Awad; Mario Zuccarello
Journal:  Lancet Neurol       Date:  2016-10-11       Impact factor: 44.182

View more
  1 in total

1.  Baseline factors associated with early and late death in intracerebral haemorrhage survivors.

Authors:  G Banerjee; G Ambler; D Wilson; I C Hostettler; C Shakeshaft; S Lunawat; H Cohen; T Yousry; R Al-Shahi Salman; G Y H Lip; H Houlden; K W Muir; M M Brown; H R Jäger; D J Werring
Journal:  Eur J Neurol       Date:  2020-04-28       Impact factor: 6.288

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.